SOW
ORKA

State of Wyoming’s Oruka Therapeutics ORKA Stock Holding History

State of Wyoming’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Buy
+2,242
New +$149K 0.02% 972

Other funds holding ORKA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

State of Wyoming's ORKA Position: Q2 2026 in Review

State of Wyoming opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 2,242 shares worth $213K. The stake represents 0.02% of the portfolio and ranks #972 among its holdings.

76 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • State of Wyoming held 2,242 shares of Oruka Therapeutics worth $213K as of Q2 2026.
  • Oruka Therapeutics was a new State of Wyoming position in Q2 2026.
  • Oruka Therapeutics made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #972 holding.
  • 76 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.